Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Proc Natl Acad Sci U S A · 2017 · PMC5740669 · PMID 29180438

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Treatment of the STZ-rats with the GHRH antagonist, MIA-602, also promoted a slight increase of mRNAs for GH, IGF1, and IGFBP-3; however, these differences did not reach statistical significance ( SI Appendix , Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.